PARSIPPANY, N.J., March 28, 2017 /PRNewswire/ -- Interpace
Diagnostics Group, Inc. (NASDAQ: IDXG) (the "Company"), a fully
integrated commercial company that provides clinically useful
molecular diagnostic tests and pathology services, announced today
that it will release 2016 year end and fourth quarter financial
results on Wednesday, March 29, 2017
after the stock market closes. The Company will also host an
investor conference call on Wednesday at 4:30 pm EDT.
Investors, analysts and members of the professional financial
community are invited to participate in the call by dialing one of
the below numbers:
Domestic: 1-877-397-0272
International: 1-719-325-4751
Conference ID: 6214396
A replay of the call will be available for two weeks from
7:30 p.m. ET on March 29, 2017, until 11:59 p.m. ET on April 12,
2017. The number for the replay is (844) 512-2921, or (412)
317-6671 for international calls; the passcode for the replay is
6214396. The audio recording of the call will also be available on
the Company's website within 24 hours of the call.
About Interpace Diagnostics Group, Inc.
Interpace is a fully integrated commercial company that provides
clinically useful molecular diagnostic tests and pathology services
for evaluating risk of cancer by leveraging the latest technology
in personalized medicine for better patient diagnosis and
management. The Company currently has three commercialized
molecular tests: PancraGEN®, for the evaluation of pancreatic cysts
and assessment of risk of concomitant or subsequent cancer;
ThyGenX®, for the diagnosis of thyroid cancer from thyroid nodules
utilizing a next generation sequencing assay; and ThyraMIR®, for
the diagnosis of thyroid cancer from thyroid nodules utilizing a
proprietary gene expression assay. Interpace's mission is to
provide personalized medicine through molecular diagnostics and
innovation to advance patient care based on rigorous science. For
more information, please visit Interpace Diagnostics' website at
www.interpacediagnostics.com
CONTACTS:
Interpace Diagnostics
Investor Relations:
Paul Kuntz
Redchip
Paul@Redchip.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/interpace-diagnostics-group-announces-timing-of-earnings-release-and-investor-conference-call-300430683.html
SOURCE Interpace Diagnostics Group, Inc.